Market Scenario

Global blood group typing market size is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 10.2% over the assessment period. Blood group typing is a method of determining the type of blood group of an individual. Blood group typing is a mandatory requirement before blood transfusion to examine the compatibility between the donor and recipient blood group. Additionally, blood typing is of significant importance in pregnant women in cases where the father of the baby has RhD positive blood group and the mother has RhD negative blood group. The global blood group typing has witnessed significant growth owing to the technological advancements in blood group detections methods. Technological advancements such as quantum dots (QDs) and magnetic beads in assays improve identification and thus enhance the clinical safety of the blood transfusion.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6410

The factors such as growing demand for blood products need for blood grouping during prenatal testing, increasing number of road incidents, growing number of road accidents and trauma cases which requires a blood transfusion, the rise in blood donations, and growing usage of blood typing in the forensic sciences. According to The American National Red Cross, about 21 million blood components are transfused each year in the US. Following the same source, each year, an estimated 6.8 million people in the US donate blood.

However, the stringent regulatory requirements for blood transfusion may hinder the growth of the global blood group typing market.

Segmentation

The global blood group typing market has been segmented into technique, test type, product and service, and end user.

The market, by technique, has been segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and others.

The market, by test type, has been segmented into antibody screening, HLA typing, ABO blood tests, cross-matching tests, and antigen typing.

The global market, on the basis of product and service, has been segmented into consumables, instruments, and services. The consumables segment has been segmented into antisera reagents, red blood cells reagents, anti-human globulin reagents, and blood bank saline.

On the basis of end user, the market has been segmented into hospitals, blood banks, clinical laboratories, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood group typing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European blood group typing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The blood group typing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood group typing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Bio-Rad Laboratories, Inc., Grifols International, S. A., Beckman Coulter, Immucor, Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, Bag Healthcare GmbH, Rapid Labs, AXO Science, Agena Biosciences, Inc., Day Medical SA, and Merck KGaA are some prominent player in the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-group-typing-market-6410